Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Trimbow and Cimetidine in Healthy Volunteers
NCT02287272Phase 1Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- May 2014
- Primary completion
- Jul 2014
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Area under the plasma concentration-time curve from time 0 to the last quantifiable concentration of Glycopyrronium Bromide. Started May 2014; status: completed.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02287272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287272.